We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81B
AUM Growth
+$6.66B
Cap. Flow
+$1.82B
Cap. Flow %
2.24%
Top 10 Hldgs %
22.31%
Holding
3,027
New
17
Increased
2,329
Reduced
595
Closed
62

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$164M
2
MSFT icon
Microsoft
MSFT
+$157M
3
AMZN icon
Amazon
AMZN
+$75.7M
4
TSLA icon
Tesla
TSLA
+$50M
5
GEHC icon
GE HealthCare
GEHC
+$45.2M

Sector Composition

Rank Sector Weight
1 Technology 25.37%
2 Healthcare 13.58%
3 Financials 12.66%
4 Consumer Discretionary 10.75%
5 Industrials 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIPO icon
2601
Hippo Holdings
HIPO
$861M
$312K ﹤0.01%
19,195
-3,041
-14% -$49.7K
ICLR icon
2602
Icon
ICLR
$12.7B
$312K ﹤0.01%
+1,461
New +$325K
DSGR icon
2603
Distribution Solutions Group
DSGR
$1.61B
$310K ﹤0.01%
13,648
+514
+4% +$10.8K
ATCX
2604
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$309K ﹤0.01%
25,314
+2,095
+9% +$21.4K
GOEV
2605
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$307K ﹤0.01%
1,022
+219
+27% +$92.8K
AFCG
2606
AFC Gamma
AFCG
$63.4M
$305K ﹤0.01%
36,668
+792
+2% +$8.05K
KALV
2607
DELISTED
KalVista Pharmaceuticals
KALV
$305K ﹤0.01%
38,822
+1,237
+3% +$9.23K
GRWG icon
2608
GrowGeneration
GRWG
$90.7M
$304K ﹤0.01%
88,757
+2,512
+3% +$10.7K
JYNT icon
2609
The Joint Corp
JYNT
$119M
$304K ﹤0.01%
18,088
-22,544
-55% -$373K
LXRX icon
2610
Lexicon Pharmaceuticals
LXRX
$1.1B
$304K ﹤0.01%
125,066
+5,949
+5% +$13.6K
STKS icon
2611
The ONE Group
STKS
$53M
$304K ﹤0.01%
37,561
+672
+2% +$5.29K
HLTH
2612
DELISTED
Cue Health Inc. Common Stock
HLTH
$304K ﹤0.01%
167,281
+4,777
+3% +$10.4K
SEAT icon
2613
Vivid Seats
SEAT
$85.4M
$303K ﹤0.01%
1,987
+86
+5% +$13.4K
TCBX icon
2614
Third Coast Bancshares
TCBX
$738M
$303K ﹤0.01%
19,309
+265
+1% +$4.75K
ITIC
2615
Investors Title Co
ITIC
$547M
$302K ﹤0.01%
2,002
+26
+1% +$4K
SEER icon
2616
Seer Inc
SEER
$120M
$300K ﹤0.01%
77,782
-564
-0.7% -$2.59K
JBIO
2617
Jade Biosciences
JBIO
$1.34B
$298K ﹤0.01%
423
+16
+4% +$13.3K
DSGN icon
2618
Design Therapeutics
DSGN
$876M
$298K ﹤0.01%
51,688
+72
+0.1% +$539
CLSK icon
2619
CleanSpark
CLSK
$3.16B
$296K ﹤0.01%
106,502
+44,261
+71% +$121K
RIGL icon
2620
Rigel Pharmaceuticals
RIGL
$750M
$296K ﹤0.01%
22,388
+561
+3% +$8.91K
NRDY icon
2621
Nerdy
NRDY
$96.7M
$295K ﹤0.01%
70,657
+1,836
+3% +$5.61K
HRT
2622
DELISTED
HireRight Holdings Corporation
HRT
$295K ﹤0.01%
27,840
+1,761
+7% +$19.8K
TTSH
2623
DELISTED
Tile Shop Holdings
TTSH
$293K ﹤0.01%
62,576
-1,663
-3% -$8.36K
MVST icon
2624
Microvast
MVST
$302M
$290K ﹤0.01%
233,486
+2,742
+1% +$3.98K
ULH icon
2625
Universal Logistics Holdings
ULH
$529M
$290K ﹤0.01%
9,956
+198
+2% +$6.42K

Similar funds

RhumbLine Advisers's Q1 2023 Portfolio in Review

As of Q1 2023, RhumbLine Advisers held 3,027 positions worth $81B, up 9% from $74.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 2.6%. RhumbLine Advisers opened 17 new positions and exited 62, leaving the 3,027-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q1 2023 buy was GE HealthCare: 633,417 shares worth $52M.
  • RhumbLine Advisers added most to Apple in Q1 2023, an estimated $164M increase.
  • RhumbLine Advisers's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $33M.
  • RhumbLine Advisers fully exited STORE Capital Corporation in Q1 2023, selling an estimated $26.2M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $81B portfolio in Q1 2023.
  • RhumbLine Advisers opened 17 new positions and closed 62 in Q1 2023.
  • RhumbLine Advisers's portfolio value rose 9% quarter-over-quarter to $81B.

Based on RhumbLine Advisers's 13F filing for Q1 2023, filed 11 May 2023.